Editorial: Clinical and molecular aspects of managing chronic urticaria: identifying endotypes, phenotypes, and factors determining responses and resistance to treatment. [PDF]
Salman A +3 more
europepmc +1 more source
Comparative efficacy and safety of biologic therapies in pediatric asthma: a comprehensive systematic review. [PDF]
Alzayed A.
europepmc +1 more source
Eosinophilic Granulomatous Polyangiitis Emerging After Omalizumab Administration: An Asthma Patient Without Systemic Corticosteroids Develops Mononeuritis Multiplex After 22 Days. [PDF]
Wang Z, Lin S, Yang J, Cheng M, Cai M.
europepmc +1 more source
Efficacy of Omalizumab therapy in a case of severe atopic dermatitis [PDF]
Jonathan Barrios +2 more
core +1 more source
Safety and efficacy of omalizumab in children aged 6 to 11 years with asthma: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Yang Y, Fang C, Jiang Z, Su X, Fan W.
europepmc +1 more source
Matching-adjusted indirect comparison analysis of omalizumab versus dupilumab in patients with chronic spontaneous urticaria. [PDF]
Mosnaim G +4 more
europepmc +1 more source
Short-term omalizumab as a potential rescue therapy for alopecia areata flares during Janus kinase inhibitor maintenance. [PDF]
Wang Q +9 more
europepmc +1 more source
Managing Alpha-Gal Allergy in a Case of Bioprosthetic TAVR. [PDF]
Patel R +5 more
europepmc +1 more source
Association Between Biologic Therapy and Reduced Acute Rhinosinusitis Episodes: A Retrospective Database Study. [PDF]
Zheng W +4 more
europepmc +1 more source

